Neo Ivy Capital Management Abbott Laboratories Transaction History

Neo Ivy Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 29, 2023	BUY	$95.53 - $114.62 $728,702 - $874,321	7,628 New	7,628 $739,000
Q3 2022 Nov 15, 2022	BUY	$96.76 - $112.03 $100,823 - $116,735	1,042 New	1,042 $101,000
Q2 2022 Aug 16, 2022	SELL	$102.07 - $123.37 $117,584 - $142,122	-1,152 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $131,351 - $160,174	1,152 New	1,152 $136,000
Q3 2021 Nov 16, 2021	SELL	$116.66 - $129.06 $53,663 - $59,367	-460 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $15,127 - $17,807	143 Added 45.11%	460 $53,000
Q1 2021 Oct 07, 2021	SELL	$108.84 - $128.23 $31,998 - $37,699	-294 Reduced 48.12%	317 $38,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $38,383 - $56,126	611 New	611 $48,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.